Medicine & Life Sciences
Dengue Virus
100%
Dengue Vaccines
96%
Vaccines
82%
Dengue
68%
Serogroup
41%
Vaccination
35%
Attenuated Vaccines
34%
Neutralizing Antibodies
32%
Human parainfluenza virus 3
31%
Viruses
25%
Flavivirus
25%
Zika Virus
22%
Infections
22%
Antibodies
17%
Volunteers
17%
Viremia
15%
Antibody Formation
15%
Epitopes
14%
Safety
13%
Immunity
12%
Severe Dengue
11%
Placebos
10%
National Institute of Allergy and Infectious Diseases (U.S.)
10%
T-Lymphocytes
9%
Culicidae
9%
Malaria
9%
HN Protein
8%
Aluminum Hydroxide
8%
Human parainfluenza virus 1
8%
Serum
8%
B-Lymphocytes
8%
Paramyxoviridae Infections
7%
Proteins
7%
Exanthema
7%
Primates
7%
Virus Diseases
7%
Macaca mulatta
7%
Immunization
6%
Malaria Vaccines
6%
Healthy Volunteers
6%
Yellow Fever Vaccine
6%
Zika Virus Infection
6%
Antigens
6%
Mutation
6%
West Nile virus
6%
Plasmodium falciparum
5%
Clinical Trials
5%
Clinical Trials, Phase I
5%
Vaccine Immunogenicity
5%
Rifaximin
5%
Agriculture & Biology
vaccines
51%
Dengue virus
35%
dengue
34%
vaccination
17%
viruses
14%
neutralizing antibodies
13%
volunteers
12%
immunogenicity
10%
antibodies
8%
neutralization
8%
infection
8%
malaria
7%
epitopes
7%
malaria vaccines
7%
yellow fever
7%
antibody formation
7%
serotypes
6%
dosage
6%
hemagglutinins
6%
live vaccines
6%
T-lymphocytes
6%
immunization
6%
Flavivirus
6%
antigens
5%
Flaviviridae
5%
Zika virus
5%
falciparum malaria
5%
Human respirovirus 3
5%
proteins
5%